PMGC Holdings ELAB
NASDAQ ELAB
$6.66 +0.56 (+9.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Interest & Investment Income (2022 - 2026)

PMGC Holdings (ELAB) posted Interest & Investment Income of $62921.0 for Q1 2026, up 122.8% sequentially from $28241.0 in Q4 2025.

PMGC Holdings (ELAB) Interest & Investment Income (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Interest & Investment Income for 5 years, with the latest figure at $62921.0 in Q1 2026.

  • Quarterly Interest & Investment Income changed N/A year-over-year to $62921.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $128214.0 (changed N/A YoY) and the FY2025 annual result came in at $118030.0, up 815.6% from the prior year.
  • Interest & Investment Income climbed to $62921.0 in Q1 2026 per ELAB's latest filing, from $28241.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $3.2 million in Q3 2022 and troughed at -$3.2 million in Q4 2022.
  • A 5-year average of $4286.5 and a median of $349.0 in 2023 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2023 and 2025: Interest & Investment Income slumped 100.0% in 2023, then jumped 25590.53% in 2025.
  • Over 5 years, Interest & Investment Income stood at -$3.2 million in 2022, then surged by 100.0% to $83.0 in 2023, then surged by 15136.14% to $12646.0 in 2024, then surged by 123.32% to $28241.0 in 2025, then surged by 122.8% to $62921.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $62921.0, $28241.0, and $24406.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 PMGC Holdings 31.22 Mn 12.43 Mn 385,691.00 83,159.00

Historic Data

Download Data
DateValue
Mar 31, 2026 62,921.00
Dec 31, 2025 28,241.00
Sep 30, 2025 24,406.00
Dec 31, 2024 12,646.00
Sep 30, 2024 95.00
Jun 30, 2024 64.00
Mar 31, 2024 86.00
Dec 31, 2023 83.00
Sep 30, 2023 25.00
Jun 30, 2023 349.00
Mar 31, 2023 5,107.00
Dec 31, 2022 -3.24 Mn
Sep 30, 2022 3.16 Mn